|
|
|
Volumn 27, Issue 2, 2000, Pages 187-193
|
|
Interferon in metastatic renal cell carcinoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
BETA INTERFERON;
CORTICOSTEROID;
CYTOKINE;
FLUOROURACIL;
GAMMA INTERFERON;
INTERFERON;
INTERLEUKIN 2;
ISOTRETINOIN;
MEDROXYPROGESTERONE ACETATE;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
VINBLASTINE;
ASTHENIA;
BONE MARROW TOXICITY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
DRUG INDUCED DISEASE;
FEVER;
GASTROINTESTINAL TOXICITY;
HUMAN;
KIDNEY CARCINOMA;
LUNG METASTASIS;
LYMPH NODE METASTASIS;
MYALGIA;
NEUROTOXICITY;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
TREATMENT OUTCOME;
ADJUVANTS, IMMUNOLOGIC;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
HUMANS;
INTERFERON-ALPHA;
INTERFERONS;
KIDNEY NEOPLASMS;
NEOPLASM METASTASIS;
PROGNOSIS;
RECOMBINANT PROTEINS;
|
|
EID: 0034039255
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (99)
|
|
References (44)
|
